EPZM - Epizyme - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $7.86. This is a potential upside of $7.86 (0%) from yesterday's end of day stock price of $0.

Epizyme's activity chart (see below) currently has 74 price targets and 68 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 58.43% with an average time for these price targets to be met of 404.92 days.

Most recent stock forecast was given by YARON WERBER from TD COWEN on 28-Jun-2022. First documented stock forecast 12-Sep-2014.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

3 years 2 months 15 days ago
(28-Jun-2022)

1/3 (33.33%)

$10.36 (47.87%)

284

Hold

$1.5

$0.03 (2.04%)

$14

3 years 2 months 15 days ago
(28-Jun-2022)

1/2 (50%)

$0.02 (1.35%)

38

Hold

$30

3 years 2 months 16 days ago
(27-Jun-2022)

2/4 (50%)

$12.54 (71.82%)

611

Buy

3 years 3 months 9 days ago
(03-Jun-2022)

2/3 (66.67%)

$9.5 (172.73%)

808

Sell

$10

4 years 1 months 2 days ago
(10-Aug-2021)

3/5 (60%)

$3.19 (46.84%)

90

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is EPZM (Epizyme) average time for price targets to be met?

On average it took 404.92 days on average for the stock forecasts to be realized with a an average price target met ratio 58.43

Which analyst has the current highest performing score on EPZM (Epizyme) with a proven track record?

ANDREW FEIN

Which analyst has the most public recommendations on EPZM (Epizyme)?

Andrew Fein works at HC WAINWRIGHT and has 5 price targets and 5 ratings on EPZM

Which analyst is the currently most bullish on EPZM (Epizyme)?

Robyn Karnauskas with highest potential upside - $27.53

Which analyst is the currently most reserved on EPZM (Epizyme)?

David Nierengarten with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?